Literature DB >> 14304249

ANTIHEPARIN ACTIVITY OF SOME HUMAN BLOOD PROTEIN FRACTIONS AND THEIR POSSIBLE RELATIONSHIP TO THROMBOSIS.

F DEWHURST, L POLLER.   

Abstract

In view of the possible relationship to thrombosis the ;anti-heparin' activity of blood protein fractions was studied. Serum and plasma were separated by continuous paper curtain electrophoresis and two different groups of fractions with anti-heparin activity found. One group was associated with the fast gamma globulins and the other with the alpha globulins. The fast gamma activity appeared to be identical with the contact activation product (activated factors XI and XII). The alpha globulin activity is different from any of the known serum clotting factors. This activity may be due to a previously unrecognized clotting factor or may be a coagulant property of certain blood proteins which act by binding heparin. The clinical implications of these findings are discussed. It is suggested that the fast gamma globulin anti-heparin fraction may be identical with Wessler's serum thrombotic accelerator and the alpha globulin activity is a separate entity.

Entities:  

Keywords:  ALPHA GLOBULIN; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BLOOD PROTEIN ELECTROPHORESIS; BLOOD PROTEINS; GAMMA GLOBULIN; HEPARIN; THROMBOSIS

Mesh:

Substances:

Year:  1965        PMID: 14304249      PMCID: PMC472937          DOI: 10.1136/jcp.18.3.339

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  The use of borate buffer in paper electrophoresis of serum.

Authors:  R CONSDEN; M N POWELL
Journal:  J Clin Pathol       Date:  1955-05       Impact factor: 3.411

2.  Massive thrombosis produced by fatty acid infusion.

Authors:  W E CONNOR; J C HOAK; E D WARNER
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

3.  The specific assay of Prower-Stuart factor and factor VII.

Authors:  K W DENSON
Journal:  Acta Haematol       Date:  1961-02       Impact factor: 2.195

4.  A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension.

Authors:  P HJORT; S I RAPAPORT; P A OWREN
Journal:  J Lab Clin Med       Date:  1955-07

5.  Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials.

Authors:  J H LEWIS; D WALTERS; P DIDISHEIM; W R MERCHANT
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

6.  A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.

Authors:  W N BELL; H G ALTON
Journal:  Nature       Date:  1954-11-06       Impact factor: 49.962

7.  Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments.

Authors:  S WESSLER
Journal:  J Clin Invest       Date:  1952-11       Impact factor: 14.808

8.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

9.  A heparin-retarded plasma clotting test.

Authors:  L POLLER
Journal:  Angiology       Date:  1954-02       Impact factor: 3.619

10.  The "in vitro" heparin tolerance test in the control of dicumarol therapy.

Authors:  J P SOULIER; A G LE BOLLOCH
Journal:  Acta Med Scand       Date:  1951-07-15
View more
  3 in total

1.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17

2.  Fatal retroperitoneal haemorrhage complicating anticoagulant therapy.

Authors:  G D Lowe; J H McKillop; A G Prentice
Journal:  Postgrad Med J       Date:  1979-01       Impact factor: 2.401

3.  Pathogenesis and conservative management of venous thrombosis and pulmonary embolism.

Authors:  P S Hunt
Journal:  Ulster Med J       Date:  1969
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.